- Stevanato Group S.p.A. (STVN, Financial) will release its Q1 2025 financial results on May 8, 2025.
- A conference call and webcast will be held at 8:30 a.m. (ET) on the same day.
- Participants are encouraged to pre-register to gain immediate call access.
Stevanato Group S.p.A. (STVN), a global leader in drug containment, drug delivery, and diagnostic solutions, has announced that it will report its financial results for the first quarter of 2025 on Thursday, May 8, 2025, at 6:30 a.m. (ET). This announcement will be followed by a conference call and webcast at 8:30 a.m. (ET) to discuss the results in detail.
The company encourages participants to pre-register for the conference call to receive a conference passcode and unique PIN for immediate access. Those interested can register through the STVN conference call pre-registration link available on the company's website.
A live, listen-only webcast will be accessible through a dedicated link, and for those unable to pre-register, alternative dial-in numbers are provided for Italy, the United Kingdom, and the United States. The webcast will be archived for three months on the Stevanato Group’s Investor Relations section of its website.
Founded in 1949, Stevanato Group offers integrated, end-to-end product and service solutions tailored to the pharmaceutical, biotechnology, and life sciences industries. Its emphasis on scientific research, technical innovation, and engineering excellence positions the company as a prominent player in the healthcare sector.
